Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3176
Invesco China Technology ETF
CQQQ
$2.5B
| $1.38M | ﹤0.01% |
26,500
-3,100
| -10% | -$169K |
2024 Q2
6 quarters
|
|
3177
Merchants Bancorp
MBIN
$2.29B
| $1.38M | ﹤0.01% |
40,404
+3,879
| +11% | +$127K |
2017 Q4
32 quarters
|
|
3178
Donegal Group Class A
DGICA
$678M
| $1.38M | ﹤0.01% |
68,872
+7,586
| +12% | +$149K |
2016 Q3
37 quarters
|
|
3179
Dine Brands
DIN
$379M
| $1.37M | ﹤0.01% |
42,762
+7,313
| +21% | +$212K |
2013 Q2
50 quarters
|
|
3180
Weis Markets
WMK
$1.83B
| $1.37M | ﹤0.01% |
21,401
-4,744
| -18% | -$317K |
2016 Q2
38 quarters
|
|
3181
Groupon
GRPN
$785M
| $1.37M | ﹤0.01% |
77,776
-11,859
| -13% | -$223K |
2022 Q1
15 quarters
|
|
3182
Red Cat Holdings
RCAT
$977M
| $1.37M | ﹤0.01% |
172,511
+50,301
| +41% | +$481K |
2024 Q3
5 quarters
|
|
|
RHLD
3183
Resolute Holdings Management
RHLD
$906M
| $1.37M | ﹤0.01% |
6,624
+643
| +11% | +$95.1K |
2025 Q1
3 quarters
|
|
3184
CALL
Zillow
Z
$6.16B
| $1.36M | ﹤0.01% |
20,000
| – | – |
2025 Q3
1 quarter
|
|
3185
Sprinklr
CXM
$1.21B
| $1.36M | ﹤0.01% |
175,342
+14,193
| +9% | +$108K |
2023 Q2
10 quarters
|
|
3186
CALL
Huntington Ingalls Industries
HII
$10.6B
| $1.36M | ﹤0.01% |
+4,000
| New | +$1.24M |
2025 Q4
0 quarters
|
|
3187
Nu Skin
NUS
$224M
| $1.36M | ﹤0.01% |
141,236
+6,763
| +5% | +$70K |
2013 Q2
50 quarters
|
|
3188
US Global Jets ETF
JETS
$825M
| $1.36M | ﹤0.01% |
48,331
-104,661
| -68% | -$2.72M |
2020 Q2
22 quarters
|
|
3189
ThredUp
TDUP
$285M
| $1.36M | ﹤0.01% |
212,177
+76,859
| +57% | +$622K |
2022 Q1
15 quarters
|
|
|
FBRT
3190
Franklin BSP Realty Trust
FBRT
$521M
| $1.36M | ﹤0.01% |
135,101
+12,504
| +10% | +$131K |
2022 Q1
15 quarters
|
|
3191
CALL
Sweetgreen
SG
$1.08B
| $1.35M | ﹤0.01% |
200,300
| – | – |
2025 Q1
3 quarters
|
|
3192
Icon
ICLR
$12.5B
| $1.35M | ﹤0.01% |
7,426
+5,456
| +277% | +$972K |
2015 Q3
41 quarters
|
|
3193
UroGen Pharma
URGN
$2.02B
| $1.35M | ﹤0.01% |
57,744
+2,125
| +4% | +$46.1K |
2018 Q1
31 quarters
|
|
3194
Varex Imaging
VREX
$784M
| $1.35M | ﹤0.01% |
116,063
+10,910
| +10% | +$128K |
2017 Q1
35 quarters
|
|
|
AEBI
3195
Aebi Schmidt Holding AG
AEBI
$847M
| $1.35M | ﹤0.01% |
106,787
-25,392
| -19% | -$303K |
2025 Q3
1 quarter
|
|
3196
National Beverage
FIZZ
$2.84B
| $1.35M | ﹤0.01% |
42,340
+7,079
| +20% | +$243K |
2013 Q2
50 quarters
|
|
3197
Rush Enterprises Class B
RUSHB
$6.62B
| $1.35M | ﹤0.01% |
35,963
-165
| -0.5% | -$6.01K |
2016 Q3
37 quarters
|
|
3198
Ezcorp Inc
EZPW
$1.86B
| $1.35M | ﹤0.01% |
69,441
-1,864
| -3% | -$35.1K |
2013 Q2
50 quarters
|
|
3199
Zumiez
ZUMZ
$204M
| $1.35M | ﹤0.01% |
51,636
+1,763
| +4% | +$42.3K |
2013 Q2
50 quarters
|
|
|
SEI
3200
PUT
Solaris Energy Infrastructure
SEI
$4.93B
| $1.34M | ﹤0.01% |
29,200
-70,800
| -71% | -$3.42M |
2025 Q3
1 quarter
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.